We compared the effectiveness of three anaesthetic regimens (propofol alone, propofol with remifentanil and sevoflurane alone), with respect to seizure duration and seizure quality in patients undergoing electroconvulsive therapy.
The induction of general anaesthesia for electroconvulsive therapy (ECT) often includes intravenous agents, such as propofol, methohexitone and thiopentone 1 . Propofol is often preferred because of rapid recovery, lower incidence of nausea and vomiting and a low incidence of adverse haemodynamic responses 2 . However, a limitation of propofol is a dose-related decrease in seizure duration 3 . The addition of a shortacting opioid to hypnotic agents has been shown to increase seizure duration in most studies (possibly by reducing the dose of propofol required) [4] [5] [6] [7] . Sevoflurane may also be used for ECT because of its rapid onset, rapid offset and low incidence of airway irritation [8] [9] [10] . However, the optimum choice for anaesthesia for ECT is still unknown.
Furthermore, although seizure duration is regarded as an important indicator of the efficacy of ECT [11] [12] [13] , it is recognised that seizure quality must also be considered 14, 15 . Much less is known about the effect of different anaesthetic regimens on seizure quality during ECT 6 .
We aimed to compare three common anaesthesia regimens: sevoflurane alone, propofol alone, and propofol with remifentanil, with respect to seizure duration, seizure quality, haemodynamic variables and recovery profiles in ECT.
MATERIALS AND METHODS
The study was approved by the University of Inonu Local Ethics Committee (number 2010/120).
The ClinicalTrials.gov identifier was nCT01759589. After obtaining written informed consent, 42 unpremedicated American Society of Anesthesiologists Physical Status I-II patients, each scheduled for six ECT sessions for a psychiatric condition, were enrolled in this prospective, randomised, observerblinded, crossover study. A crossover design was chosen because of the high degree of variability in the response to medications and response to ECT among patients. Having the patients serve as their own comparator decreased the effect of inter-patient variability, increased the power of the study and permited smaller sample sizes. Additionally, with this design patients served as their own controls. The exclusion criteria included involuntary patient status, <18 years or >65 years, patients with known or selfdeclared needle or mask phobia, pregnancy, asthma, cerebrovascular disease, history of myocardial infarction in the previous six months, atrial fibrillation or flutter, heart block or a known family history of reactions to the study drugs.
The patients enrolled in the study were allocated by computer-generated random numbers to receive one of three different anaesthesia regimens: propofol alone (Group P), propofol and remifentanil (Group r), or sevoflurane alone (group S) for their initial ECT session. The patients subsequently received an alternative study drug in their next session, such as from propofol 1 mg/kg alone to propofol 0.5 mg/kg and remifentanil 1 µg/kg, from propofol 0.5 mg/kg and remifentanil 1 µg/kg to sevoflurane alone 6%, or from sevoflurane alone 6% to a continuing alternation between drugs at each session, until the sixth session. ECT was administered three times per week.
No premedication or anticholinergic drug was administered. Routine monitoring was applied. The patients in Group P received 1 mg/kg propofol IV (over 15 seconds); patients in Group R received remifentanil 1 µg/kg IV (over 60 seconds) and 0.5 mg/kg propofol IV (over 15 seconds). Consciousness was evaluated by the absence of response to verbal commands and the loss of eyelash reflex. additional propofol was given as required in 10 mg increments to achieve loss of consciousness in Groups P and R if required. The total dose of propofol was recorded. In group S, sevoflurane was started at 6% for induction until loss of consciousness and continued at 1% until the electrical stimulus was delivered, at which time it was stopped.
After the loss of consciousness, a pneumatic tourniquet was applied to the arm and inflated to isolate the circulation of the arm and permit an accurate assessment of the motor seizure. Thereafter, 1 mg/kg succinylcholine was administered intra-venously in the contralateral arm and ventilation was assisted with 100% oxygen (1% sevoflurane in 100% oxygen in Group S). Then, an electrical stimulus was delivered via bifrontotemporal electrodes using a Thymatron System IV, ECT Instrument (Somatics Inc., Lake Bluff, IL, USA). The seizure threshold was titrated during the first session, beginning at 5% charge (frequency: 10 Hz; pulse width: 0.5 millisecond) and restimulating at increments of 5% until evidence of generalised seizure activity was observed (or up to 25% charge, at which point stimulus was given at 100% charge). These data were not included in the study. Subsequent treatments were administered at a level of 150% of the determined seizure threshold. The duration of the motor seizure was recorded as the time from the ECT stimulus to the cessation of tonic-clonic motor activity in the 'isolated' arm; the duration was assessed by an observer through a window outside of the operating theatre to blind the observer to the anaesthetic agent used. The electroencephalogram (EEG) tracing was recorded continuously using two frontal electrodes. The EEG seizure duration, early and midictal EEG amplitude, and postictal suppression index (PSI) were recorded from the EEG traces obtained during the seizure.
Non-invasive mean arterial blood pressure, heart rate and peripheral oxygen saturation values were recorded immediately before administration of the medication (t0), at one (t1), three (t2) and ten (t3) minutes after the seizure ended. The peak heart rate during the seizure was recorded from the ECG. The time from the end of succinylcholine administration to the recovery of spontaneous breathing, eye-opening and obeying verbal commands were recorded. The presence of complications such as arrhythmia, laryngospasm and agitation were recorded.
The main outcome of this study was seizure duration. Thus, the power calculation was based on seizure duration and was similar to other studies' power calculations 7, 9, 10 . In our study, we used post-hoc power analysis for the related study design using NCSS and PASS software. For a power of 80% and a=0.05, a minimum sample size of 70 ECT sessions in each group was required to detect a 10% difference, if the estimated mean seizure duration was 48 seconds and the standard deviation of the seizure duration was 23 seconds. Statistical analysis was performed using SPSS for Windows, version 15.0 (SPSS Inc. Headquarters, Chicago, IL). The normality of the continued variables in the groups was assessed using Kolmogorov-Smirnov test. among the group differences in heart rate, mean arterial blood pressure, motor and EEG seizure duration times, PSI, early and midictal EEG amplitude, and recovery time were evaluated using repeated measures analysis of variance test. Multiple comparisons were performed using Bonferroni test. Pearson's chi-square test and yate's correction were used to compare agitation and additional propofol requirements among the groups, respectively. A P value less than <0.05 was considered to be statistically significant. The results are expressed as numbers (n) or mean ± standard deviation.
RESULTS
Three patients were excluded during the study; one patient developed severe hypertension during ECT in Group P and two patients refused further study treatments after the first study treatment in group S. There were 27 male and 12 female patients with a mean age of 33.8±10.3 years (range 18-57 years) and a mean weight of 73.6±14.9 kg (range 42-103 kg). The clinical diagnoses of the patients were schizophrenia for 23 patients, bipolar affective disorder for seven patients and treatment resistant depression for nine patients.
The patients completed a total of 234 ECTs over six separate treatment sessions. The mean electrical dose was not significantly different among the groups. The mean propofol dose was 79.8±21.1 mg in group p and 44.0±16.5 mg in Group R. The propofol requirement was 1.1±0.1 mg/kg in Group P and 0.6±0.2 mg/kg in Group R (P <0.001). The mean motor and EEG seizure durations were significantly longer in groups P (32.7±13.5 seconds) and R (35.0±12.2) compared to group S (25.1±9.7, P <0.001). The PSI, early and midictal EEg amplitude values were not significantly different among the groups ( Table 1) .
The time to spontaneous breathing, eye-opening and obeying commands was similar among the three groups, although the study was not powered to assess these outcomes ( Table 1 ). The heart rate and mean arterial blood pressure changes appeared similar between the groups. During the recovery period, agitation was observed in three sessions in Group P, four sessions in group r and five sessions in group S.
DISCUSSION
In this study, propofol alone and propofol with remifentanil were associated with significantly longer seizure durations during ECT than sevoflurane. however, there were no significant differences between the three anaesthetic regimens in relation to seizure quality.
While short-acting intravenous agents, such as propofol, methohexitone and thiopentone, are used in general anaesthesia for ECT, a short-acting opioid can also be added to these agents to prolong seizure duration, increase seizure quality and reduce haemodynamic responses to ECT [1] [2] [3] [4] [5] [6] [7] . Moreover, volatile agents such as sevoflurane can be used instead of intravenous anaesthetics for similar purposes [8] [9] [10] . Some studies 8-10 report a longer seizure duration with sevoflurane in ECT, whereas others 16-18 report a short seizure duration. It has also been suggested that seizure duration is inversely related to the duration of sevoflurane dosing 19 . In our study we continued sevoflurane after the loss of consciousness and discontinued it only after electrical stimulation was completed. This may explain the shorter seizure duration in the sevoflurane group. alternatively, the differences in seizure duration may be related to differences in anaesthetic depth, rather than differences in anaesthetic agent. For this reason we avoided induction doses of propofol >1.0 mg/kg, which may decrease the seizure duration 20, 21 .
The effect of adding an ultra short-acting synthetic opioid, such as remifentanil, to the hypnotic agent on seizure duration is controversial [4] [5] [6] [7] . The addition of remifentanil to hypnotic agents has been shown to increase seizure duration in several studies [4] [5] [6] [7] . It is reported that remifentanil produces longer seizures by allowing a dose reduction or elimination of other anaesthetics that may have dose-related anticonvulsant properties 22 . Although the propofol dose in our study in Group R was lower, we found no significant difference in seizure duration between Group P and R. In a retrospective study, even though the utilised hypnotic agent doses were lower, no significant difference was detected with regard to seizure duration 23 .
another factor that may have influenced seizure duration was electrode placement. All of the studies that included a high proportion of unilateral treatments reported longer seizures with remifentanil, whereas the studies that found no difference in seizure duration used bilateral placement exclusively 22 . Similar to these studies, the reason for our study result may have been using bilateral placement of electrodes.
Although seizure duration is regarded as an indicator of the efficacy of ECT, currently the importance of seizure duration is being questioned [11] [12] [13] . Some studies report that ictal EEG indices may be markers of relative stimulus intensity that might indicate a successful treatment 11 . A retrospective study showed that remifentanil increased PSI 24 . The mean PSI value was 68 in the remifentanil group, which is lower than the PSI value in this study. In that study, treatment used on unilateral and bilateral electrode placement methods 24 . Low-dose unilateral ECT is associated with a decrease in PSI 25 . However, we provided bilateral treatment to all patients in this study. Therefore, we propose that this difference in the PSI values is caused by the difference between the methods. In addition to reporting no difference between the groups with regard to early ictal amplitude, which was similar to the results of our study, Dinwiddie et al 6 stated that their remifentanil group had better scores in other seizure quality indicators. Nevertheless, the PSI values were not studied.
Although many ECT studies using intravenous anaesthetics and assessing PSI have been published, we identified only one study that examined pSi using sevoflurane 9 . However, the unilateral and bilateral electrical stimulation methods used in that study were different from those used in our study. In our study, the pSi values were not significantly different among the groups, although our sample size may be too small to allow for the determination of clinically significant differences in the PSI values.
Parasympathetic stimulation followed by a sympathetic stimulation is observed during ECT due to autonomic nerve stimulation. Increases of 20-25% and 20-50% in the heart rate and blood pressure, respectively, are observed 20 . In our study, the heart rate and mean arterial blood pressure changes were as expected but appeared to be similar across the three groups.
As ECTs are often performed on an outpatient basis, the anaesthetic agents used should have rapid recovery profiles. all of the three anaesthetic methods used in our study had short recovery periods in terms of spontaneous breathing, eye-opening and obeying commands ( Table 1) .
There are several limitations to this study. First, the therapeutic outcome was not investigated because of the alternating administrations within subjects. Second, the depth of the anaesthesia may not have been equal across the groups. We may also have had insufficient power to exclude some clinically relevant differences. For this reason, further studies using blinded psychiatric assessment and larger numbers are required to fully assess the effects of these three regimens for ECT.
We conclude that our anaesthetic regimen of propofol alone or propofol with remifentanil had similar effects on seizure duration during ECT, which were significantly longer than our sevoflurane regimen, but that there were no significant differences in seizure quality between the three regimens.
